Company Filing History:
1 out of 164 
1 out of 38 
Years Active: 2015
Title: The Innovations of Steven Shijun Ren
Introduction
Steven Shijun Ren is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on Y receptor agonists. His research has led to advancements that enhance the pharmacokinetic profiles of these compounds, making them more effective for medical use.
Latest Patents
Steven holds a patent for "Microcrystalline Y receptor agonists." This patent discloses microcrystals of Y receptor agonists, as well as microcrystalline pellets and suspensions of these compounds. The pharmaceutical compositions derived from these microcrystals have been shown to have prolonged pharmacokinetic profiles, which are beneficial for once daily or once weekly administration.
Career Highlights
Throughout his career, Steven has worked with notable companies in the pharmaceutical industry. He has been associated with Amylin Pharmaceuticals, Inc. and AstraZeneca Pharmaceuticals LP. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Due to space constraints, the details of Steven's collaborations will not be included.
Conclusion
Steven Shijun Ren's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions through his patent on Y receptor agonists highlight the importance of research and development in creating effective medical treatments.